Caris Life Sciences Insiders Convert Preferred to 3.5M Common Shares
Rhea-AI Filing Summary
Form 4 overview: Caris Life Sciences, Inc. (ticker CAI) received a Form 4 jointly filed by 10% owners ADAPT I Ltd. and Carisome I, L.P. reflecting an internal capital-structure event dated 20 June 2025.
Key transaction: On 06/20/2025 the holders converted Series A Preferred Stock into 3,500,003 shares of common stock (transaction code “C”). The filing lists a conversion price of $0, confirming the shares were issued automatically, not purchased on the open market.
- Conversion ratio: each preferred share → 0.25 common shares (Footnote 1)
- Shares acquired: 3,500,003 (all classified “A” for acquired)
- Post-transaction common shares beneficially owned: 16,943,232
Ownership structure: Footnote 2 breaks the holdings into 8,528,805 shares held by ADAPT I Ltd. and 8,414,427 shares held by Carisome I, L.P. Both entities are controlled via separate family trusts for which David D. Halbert serves as trustee; Halbert disclaims beneficial ownership beyond his pecuniary interest.
Capital-structure implications: The automatic conversion occurred “upon the closing of the initial public offering” of CAI common stock, indicating that all outstanding Series A Preferred shares held by these entities are now common equity (Footnote 3). No derivative securities remain in their indirect ownership following the conversion.
Material takeaways for investors: • Preferred-to-common conversion simplifies the equity stack after the IPO. • Insider collective ownership stands at roughly 17 million shares, highlighting continued significant influence by Halbert-controlled vehicles. • No open-market buying or selling occurred, so the filing is primarily informational rather than indicative of valuation views.
Positive
- Preferred stock automatically converted into common equity, simplifying Caris Life Sciences’ capital structure post-IPO.
Negative
- 3,500,003 additional common shares enter the outstanding pool under insider control, potentially diluting existing common shareholders.
Insights
TL;DR: Insiders converted Series A into 3.5 M common shares; no cash paid, ownership now ~17 M shares.
The filing records a mandatory preferred-to-common conversion tied to the IPO closing. Because the conversion price is $0, the event is bookkeeping rather than a capital infusion. The insiders’ aggregate stake increases on the common share count, signalling strong post-IPO control but not signalling market sentiment. The disappearance of the preferred layer modestly improves capital-structure clarity, generally neutral to valuation aside from the incremental share count already anticipated in IPO prospectus.
TL;DR: Preferred class eliminated, ownership transparency improves; insider control remains high.
From a governance standpoint, converting the Series A Preferred into common stock removes special rights typically attached to preferred shares, aligning insiders’ incentives with public holders. However, the 16.9 M common shares now controlled by Halbert-linked entities underscore concentrated ownership, which can both ensure strategic consistency and limit minority influence. The filing is routine post-IPO housekeeping and carries limited immediate market impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series A Preferred Stock | 14,000,000 | $0.00 | -- |
| Conversion | Common Stock | 3,500,003 | $0.00 | -- |
Footnotes (1)
- Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock. The Common Stock reported herein includes 8,528,805 shares of Common Stock held of record by ADAPT I Ltd. and 8,414,427 shares of Common Stock held of record by Carisome I, L.P. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. David D. Halbert is the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held of record by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein. The preferred stock reported herein includes 3,500,003 shares of Common Stock underlying Series A Preferred Stock held of record by ADAPT I Ltd..
